Skip to content

FLOREMISA

Absorbed by MULTIPHARMA on 23-12-2014 KBO/BCE: BE 0874.838.743

Annual accounts 2013

full format, filed on 16-06-2014, 45 days before the deadline
€91,003
▲ 60.2%
€78,594
▲ €97,846
€66,431
▲ €94,939
-€125,911
▲ €37,922
24.7%
▲ 16.4 percentage points
0.12
▲ 0.03

Turnover is estimated at about €270,000, probably between €160,000 and €530,000.

Balance sheet

balance sheet total €405,773 on 31-12-2013
What the company ownsHow it is paid for

in euro

in euro

Staff

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend201320122011201020092008200720062005
80,322-17,811-3,930-11,04319,09970,91251,70651,428-
68,159-27,067-14,235-22,0024,94339,16523,83522,819-
063904,59049800389,932-
16,848-962-781-7,188-6,86910,5305,817-12,021-
-125,911-163,833-118,861-83,627-36,623-19,456-34,422-44,809-
24.7%8.4%14.9%15.3%17.8%15.1%10.8%7.7%100.0%
0.120.090.200.590.830.930.810.57-
3.0410.975.725.554.635.628.2211.98-
66.2%-84.0%-24.8%-29.8%4.8%40.0%40.1%64.1%-
16.4%-7.0%-3.7%-4.6%0.9%6.0%4.4%4.9%-
58 days--------

EBIT margin not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend201320122011201020092008200720062005
Balance sheet: assets
20/58 405,773406,236419,639510,243568,929637,575532,724448,87912,400
21/28 388,000389,729390,531391,760388,398388,000388,657389,295-
22/27 -1,7292,5313,76039806571,295-
24 -1,7292,5313,76039806571,295-
28 388,000388,000388,000388,000388,000388,000388,000388,000-
29/58 17,77316,50729,108118,483180,531249,575144,06759,58412,400
40/41 -15,56825,184112,879170,113232,806137,58258,716-
40 -15,56824,094112,627168,672232,806137,58258,716-
41 --1,0902521,441----
54/58 17,7739251,8872,6689,85616,7256,19637912,400
490/1 -142,0372,93656244289489-
Balance sheet: equity and liabilities
10/49 405,773406,236419,639510,243568,929637,575532,724448,87912,400
10/15 100,35933,92862,43777,900101,13096,28657,77834,58112,400
10/11 12,40012,40012,40012,40012,40012,40012,40012,400-
10 --------12,400
100 18,60018,60018,60018,60018,60018,60018,60018,60018,600
101 6,2006,2006,2006,2006,2006,2006,2006,200-
13 1,8601,86088,73088,73088,73083,88645,37822,181-
130 1,8601,8601,8601,8601,8601,8601,8601,860-
133 --86,87086,87086,87082,02643,51820,321-
14 86,09919,668-38,693-23,230-----
17/49 305,414372,307357,203432,343467,799541,289474,946414,298-
17 161,730185,716209,233230,233250,645272,207291,207309,905-
170/4 161,730185,716209,233230,233250,645272,207291,207309,905-
42/48 143,685180,340147,969202,111217,154269,031178,489104,393-
42 23,98621,81429,96829,33529,33528,52032,83220,000-
43 -614-01603-
430/8 -614-01603-
44 5,9514,36813,94411,3833,60735,77514,2344,037-
440/4 5,9514,36813,94411,3833,60735,77514,2344,037-
46 -----03,476--
45 1,52381,39628,17726,39971,27992,19748,03920,840-
450/3 1,52367,07716,8365,06446,04865,93529,75614,973-
454/9 -14,31911,34221,33525,23126,26118,2835,867-
47/48 112,22572,75675,865134,994112,933112,52379,90859,514-
492/3 -6,2511-0515,250--
Income statement
9900 91,00356,81570,12538,55579,644131,59391,83665,155-
60/61 37,540--------
62 -85360,85071,34846,23357,00258,58237,88512,902-
630 1,7291,4411,2281,228100657638638-
640/8 11,53413,7762,7073,3663,5422,0992,246825-
9901 78,594-19,252-5,159-12,27219,00070,25551,06850,790-
75/76B 172391673935-
75 172391673935-
65/66B 11,3979,25810,31211,15011,75412,75213,88116,013-
65 11,3979,25810,31211,15011,75412,75213,88116,013-
9903 67,370-28,506-15,461-23,4067,25257,50737,19734,812-
67/77 93922-1762,40918,99914,00012,631-
9904 66,431-28,509-15,463-23,2304,84438,50823,19722,181-
9905 66,431-28,509-15,463-23,2304,84438,50823,19722,181-
Appropriation of the result
9906 86,099-67,202-38,693-23,2304,84438,50823,19722,181-
791/2 -86,870-------
691/2 ---04,84438,50823,19722,181-
6920 ------01,860-
6921 ---04,84438,50823,19720,321-
Social balance sheet
9087 -1.11.30.8111--
Hours worked1013 -1,8042,2181,5171,6851,7481,145--
Document PDFPDFPDFPDFPDFPDFPDFPDFPDF

Source: Annual accounts 2013 (PDF), filed on 16-06-2014.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2013 full format 16-06-2014 2014-19100097 PDF
31-12-2012 full format 24-07-2013 2013-35500467 PDF
31-12-2011 full format 27-06-2012 2012-23400395 PDF
31-12-2010 full format 29-08-2011 2011-48400307 PDF
31-12-2009 full format 17-06-2010 2010-19600541 PDF
31-12-2008 full format 16-06-2009 2009-24400010 PDF
31-12-2007 full format 11-07-2008 2008-39900342 PDF
31-12-2006 full format 20-06-2007 2007-26000327 PDF
31-12-2005 full format 24-07-2006 2006-51601817 PDF

Insights on FLOREMISA

The operating result for 2013 is a profit of €78,594, after a loss of €19,252 in 2012. It is the highest result since 2006.

Debt's share of the balance-sheet total falls from 91.6% to 75.3%. Equity is higher and debt is lower.